1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618-24.
2. Melbye H, Straume B, Aasebo U, Dale K. Diagnosis of pneumonia in adults in general practice. Relative importance of typical symptoms and abnormal chest signs evaluated against a radiographic reference standard. Scand J Prim Health Care. 1992;10:226-33.
3. Melbye H, Straume B, Aasebo U, Brox J. The diagnosis of adult pneumonia in general practice. The diagnostic value of history, physical examination and some blood tests. Scand J Prim Health Care . 1988;6:111-7.
4. Wipf JE, Lipsky BA, Hirschmann JV, et al. Diagnosing pneumonia by physical examination—relevant or relic? Arch Intern Med. 1999;159:1082-7.
5. Zaat JOM, Stalman WAB, Assendelft WJJ. Groaning, moaning and percussion. A systematic review on the diagnostic value of history and physical examination in patient with a suspicion of pneumonia. Huisarts Wet. 1998;41:461-9.
6. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997;278:1440-5.
7. Kuyvenhoven MM, Verheij TJ, de Melker RA, van der Velden J. Antimicrobial agents in lower respiratory tract infections in Dutch general practice. Br J Gen Pract 2000;50:133-4.
8. Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the UK: implications for developing management guidelines. Respir Med 1997;91:427-34.
9. Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK. Treatment of acute bronchitis in adults. A national survey of family physicians. J Fam Pract. 1998;46:469-75.
10. Ortqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemother 1995;35:205-12.
11. Janknegt R, Wijnands WJ, Stobberingh EE. Antibiotic policies in Dutch hospitals for the treatment of pneumonia. J Antimicrob Chemother 1994;34:431-42.
12. van der Werf GT, Smith RJA, Stewart RE, Meyboom-de Jong B. Spiegel op de huisarts: over registratie van ziekte, medicatie en verwijzingen in de geautimatiseerde huisartsenpraktijk. Groningen, the Netherlands: Disciplinegroep Huisartsgeneeskunde, University of Groningen; 1998: 1-181.
13. Stokx LJ, Foets M. Het voorschrijven van geneesmiddelen in de huisartspraktijk. Deel II [Prescribing drugs in general practice]. Utrecht: NIVEL; 1994.
14. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996;101:508-15.
15. Berntsson E, Lagergard T, Strannegard O, Trollfors B. Etiology of community-acquired pneumonia in out-patients. Eur J Clin Microbiol 1986;5:446-7.
16. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995;50:543-7.
17. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore). 1990;69:307-16.
18. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671-4.
19. Jonsson JS, Sigurdsson JA, Kristinsson KG, Guthnadottir M, Magnusson S. Acute bronchitis in adults. How close do we come to its aetiology in general practice? Scand J Prim Health Care. 1997;15:156-60.
20. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993;341:511-4.
21. Niederman MS, Bass JB, Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. merican Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418-26.
22. Mandell LA, Niederman M. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 1993;4:25-8.
23. Marrie TJ. Community acquired pneumonia. Clin Infect Dis 1994;18:501-15.
24. Poirier R. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia. J Antimicrob Chemother 1991;27:109-16.
25. Tilyard MW, Dovey SM. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice. Diagn Microbiol Infect Dis 1992;15:S97-101.
26. Zeluff BJ, Lowe P, Koornhof HJ, Gentry LO. Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 1988;7:69-71.
27. Schonwald S, Barsic B, Klinar I, Gunjaca M. Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia. Scand J Infect Dis 1994;26:706-10.
28. Young RA, Gonzalez JP, Sorkin EM. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1989;37:8-41.
29. de Neeling AJ, Pelt van W, Hendrix MGR, et al. Antibiotica resistentie in Nederland. Deel III: Gram-positieve bacteriën. Infect Bull. 1997;8:211-5.
30. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-7.
31. Wilson S, Delaney BC, Roalfe A, et al. Randomized controlled trials in primary care: case study. BMJ 2000;321:24-7.
32. Ortqvist A, Hedlund J, Grillner L, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990;3:1105-13.
33. Ortqvist A, Valtonen M, Cars O, Wahl M, Saikku P, Jean C. Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group. Chest. 1996;110:1499-506.
34. Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990;84:377-85.
35. Trigg CJ, Wilks M, Herdman MJ, Clague JE, Tabaqchali S, Davies RJ. A double-blind comparison of the effects of cefaclor and amoxycillin on respiratory tract and oropharyngeal flora and clinical response in acute exacerbations of bronchitis. Respir Med 1991;85:301-8.
36. Karalus NC, Garrett JE, Lang SD, et al. Roxithromycin 150 mg bid versus amoxicillin 500 mg/clavulanic acid 125 mg tid for the treatment of lower respiratory tract infections in general practice. Infection 1995;23:S15-20.
37. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med 1997;337:491-2.
38. de Neeling AJ. Antibioticagebruik en het optreden van resistentie. National Institute of Public Health and the Environment/Volksgezondheid Toekomst Verkenning 1997;B3:793-800.
39. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441-6.
40. Wood MJ. More macrolides. BMJ 1991;303:594-5.
41. Wort SJ, Rogers TR. Community acquired pneumonia in elderly people. Current British guidelines need revision. BMJ . 1998;316:1690.-
42. Bartlett JB. Management of respiratory tract infections. Baltimore, Md: Williams & Wilkins; 1997: 121.
43. King DE, Williams WC, Bishop L, Shechter A. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 1996;42:601-5.
44. Lode H, Garau J, Grassi C, et al. Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. Eur Respir J 1995;8:1999-2007.
45. Urquhart J. Partial compliance in cardiovascular disease: risk implications. Br J Clin Pract 1994;suppl:2-12.
46. Cramer JA, Ouelette VL, Mattson RH. Effect of microelectronic observation on compliance. Epilepsia 1990;31:617-8.
47. Favre O, Delacretaz E, Badan M, Glauser M, Waeber B. Relationship between the prescriber’s instructions and compliance with antibiotherapy in outpatients treated for an acute infectious disease. J Clin Pharmacol 1997;37:175-8.
48. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet. 1994;27:202-15.
